MA56396A - Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide - Google Patents

Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide

Info

Publication number
MA56396A
MA56396A MA056396A MA56396A MA56396A MA 56396 A MA56396 A MA 56396A MA 056396 A MA056396 A MA 056396A MA 56396 A MA56396 A MA 56396A MA 56396 A MA56396 A MA 56396A
Authority
MA
Morocco
Prior art keywords
fluoropyridin
polymorphs
pyrimidin
carboxamide
pyrrole
Prior art date
Application number
MA056396A
Other languages
English (en)
Inventor
Bradley P Morgan
Matthew W Peterson
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of MA56396A publication Critical patent/MA56396A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA056396A 2019-06-27 2020-06-26 Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide MA56396A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962867834P 2019-06-27 2019-06-27

Publications (1)

Publication Number Publication Date
MA56396A true MA56396A (fr) 2022-05-04

Family

ID=71728912

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056396A MA56396A (fr) 2019-06-27 2020-06-26 Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide

Country Status (14)

Country Link
US (1) US20220315558A1 (fr)
EP (1) EP3990447A1 (fr)
JP (1) JP2022538119A (fr)
KR (1) KR20220079512A (fr)
CN (1) CN114364669A (fr)
AU (1) AU2020308017A1 (fr)
BR (1) BR112021025659A2 (fr)
CA (1) CA3142514A1 (fr)
CL (1) CL2021003380A1 (fr)
IL (1) IL289397A (fr)
MA (1) MA56396A (fr)
MX (1) MX2021015468A (fr)
PH (1) PH12021553250A1 (fr)
WO (1) WO2020264358A1 (fr)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239345A (en) 1965-02-15 1966-03-08 Estrogenic compounds and animal growth promoters
US4411890A (en) 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4036979A (en) 1974-01-25 1977-07-19 American Cyanamid Company Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
AU628322B2 (en) 1988-01-28 1992-09-17 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
AU637316B2 (en) 1988-01-28 1993-05-27 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US5663146A (en) 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5776983A (en) 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5488064A (en) 1994-05-02 1996-01-30 Bristol-Myers Squibb Company Benzo 1,3 dioxole derivatives
US5491134A (en) 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6236946B1 (en) 1995-12-13 2001-05-22 Thomas S. Scanlan Nuclear receptor ligands and ligand binding domains
US5770615A (en) 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
GB9713739D0 (en) 1997-06-27 1997-09-03 Karobio Ab Thyroid receptor ligands
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
SG11202006085PA (en) * 2017-12-26 2020-07-29 Cytokinetics Inc Process for the preparation of an amino-pyrimidine and intermediates thereof

Also Published As

Publication number Publication date
MX2021015468A (es) 2022-01-24
WO2020264358A1 (fr) 2020-12-30
AU2020308017A1 (en) 2022-02-10
JP2022538119A (ja) 2022-08-31
CN114364669A (zh) 2022-04-15
EP3990447A1 (fr) 2022-05-04
KR20220079512A (ko) 2022-06-13
BR112021025659A2 (pt) 2022-02-08
PH12021553250A1 (en) 2022-09-19
IL289397A (en) 2022-02-01
CL2021003380A1 (es) 2022-08-19
US20220315558A1 (en) 2022-10-06
CA3142514A1 (fr) 2020-12-30

Similar Documents

Publication Publication Date Title
PL3972471T3 (pl) Urządzenie do czyszczenia powierzchni przeznaczonych do chodzenia
EP3891350A4 (fr) Joint de sous-plancher
DK3934562T3 (da) Klæberetainer
EP3814341A4 (fr) Inhibiteurs de récepteurs erbb
EP3903761A4 (fr) Objet en zircone calcinée convenant à la dentisterie
EP3737803A4 (fr) Joint de sous-plancher
DK3750456T3 (da) Fleksibelt element til formning af engangsbestik
EP3869576A4 (fr) Film piézoélectrique
EP4078942C0 (fr) Fusion d'images
EP4039336A4 (fr) Agent nettoyant
EP4030344A4 (fr) Objet imprimé
EP3669520A4 (fr) Transmission d'images
EP3965803A4 (fr) Inhibiteurs de kinase d'adhésion focale à petites molécules (fak)
EP4037703A4 (fr) Formulations d'anticorps anti-connexine
EP4001297C0 (fr) Protéine l1 de papillomavirus chimérique
EP3958804A4 (fr) Applicateur de lentille
EP3985747A4 (fr) Élément piézoélectrique
DK4197485T3 (da) System til scanning af flere dentale genstande
MA56396A (fr) Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide
EP4080908A4 (fr) Film piézoélectrique
HK40073229A (en) Polymorphs of 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide
IT201900023613A1 (it) Impianto flessibile di verniciatura
IT201900004815A1 (it) Membro di giunzione per pannelli
UA41625S (uk) Етикетка до клею «будапрен»
UA41771S (uk) Етикетка до клею «десмокол»